SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-13-003283
Filing Date
2013-09-10
Accepted
2013-09-10 17:20:13
Documents
4
Period of Report
2013-10-15
Effectiveness Date
2013-09-10

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT admp-def14a_101513.htm DEF 14A 680187
2 proxy3.jpg GRAPHIC 185321
3 proxy4.jpg GRAPHIC 105282
4 admp.jpg GRAPHIC 5422
  Complete submission text file 0001387131-13-003283.txt   1089552
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 000-26372 | Film No.: 131088933
SIC: 2834 Pharmaceutical Preparations